
#1891Medicine & HealthFront Page19 March 2026
Remodelling Resistance: The Next Phase of HNSCC Immunotherapy
Researchers are abandoning empirical monotherapy in favour of precision-guided combinations to treat head and neck cancers. By actively remodelling the tumour microenvironment, these new strategies aim to make immunologically inert tissues vulnerable to immune attack.
By Okuyama, Naruse, Matsushita, Fujimoto, Yanamoto, Lei, Hu
